What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2023
2BInformed: The EPA’s Impact on Supply Chains and Climate Change, and Defining “Unreasonable Risk”
2BInformed: Understanding the EPA’s New PFAS Strategic Roadmap and Upcoming PBT Regulations
2BInformed: Overview of PFAS and Related EPA Regulations; EPA’s New Chemical Program Under Amended TSCA
2BInformed: How TSCA Amendments Impact Industries and Managing the EPA’s Risk Evaluations
2BInformed: The Future of Fluoride in Drinking Water, the New TSCA Fees Rule, and the Drinking Water Contaminant Candidate List 5
Wiley Biotech Briefings – An Advanced Course for the Regulatory Professional: TSCA and Industrial Biotechnology
On November 14, 2024, the U.S. Environmental Protection Agency (“EPA”) determined that 1,4-dioxane presents an unreasonable risk of injury to human health under its conditions of use....more
Over the last six years, our firm has written extensively about 1,4-Dioxane, from U.S. EPA’s proclamations to state laws and regulations, litigation, and distinctions between federal and state perspectives. (see compilation...more
Per- and polyfluoroalkyl substances (PFAS) are a large class of synthetically created organic chemical compounds that have been at the forefront of complex environmental and legal issues in recent years. While many PFAS...more